Home » BOLDER BIOTECHNOLOGY RECEIVES NIH GRANT
BOLDER BIOTECHNOLOGY RECEIVES NIH GRANT
Bolder BioTechnology has been awarded a grant for more than $300,000 from NIH. The grant will be used to develop the company's proprietary long-acting growth hormone product. The product is being analyzed as a potential treatment for growth hormone deficiency, short stature in children and HIV-related wasting.
Denver Business Journal (http://www.bizjournals.com/denver/stories/2005/01/10/daily35.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May